Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 22, 2022 - Issue 12: Biological therapies for psoriasis
Submit an article Journal homepage
207
Views
4
CrossRef citations to date
0
Altmetric
Review

Use of biologics during the COVID-19 pandemic: lessons learned from psoriasis

Paolo GisondiDepartment of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1777-9001View further author information
ORCID Icon,
Davide GeatDepartment of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, ItalyView further author information
,
Francesco BellinatoDepartment of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, ItalyORCID Iconhttps://orcid.org/0000-0002-6163-6921View further author information
ORCID Icon &
Giampiero GirolomoniDepartment of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, ItalyORCID Iconhttps://orcid.org/0000-0001-8548-0493View further author information
ORCID Icon
Pages 1521-1529 | Received 07 Jun 2022, Accepted 03 Aug 2022, Published online: 08 Aug 2022

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Luca Potestio, Fabrizio Martora, Gabriella Fabbrocini, Teresa Battista & Matteo Megna. (2023) Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis. Psoriasis: Targets and Therapy 13, pages 11-18.
Read now
Matteo Megna, Elisa Camela, Teresa Battista, Lucia Genco, Fabrizio Martora, Matteo Noto, Vincenzo Picone, Angelo Ruggiero, Giuseppe Monfrecola, Gabriella Fabbrocini & Luca Potestio. (2023) Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients. Expert Opinion on Drug Safety 22:1, pages 43-58.
Read now
Matteo Megna, Elisa Camela, Teresa Battista, Lucia Genco, Fabrizio Martora, Matteo Noto, Vincenzo Picone, Angelo Ruggiero, Giuseppe Monfrecola, Gabriella Fabbrocini & Luca Potestio. (2023) Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patients. Expert Opinion on Drug Safety 22:1, pages 25-41.
Read now

Articles from other publishers (1)

Ricardo Ruiz-Villaverde, Lourdes Rodriguez Fernandez-Freire, Pilar Font-Ugalde & Manuel Galan-Gutierrez. (2022) Tildrakizumab: Efficacy, Safety and Survival in Mid-Term (52 Weeks) in Three Tertiary Hospitals in Andalucia (Spain). Journal of Clinical Medicine 11:17, pages 5098.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.